Ticker Details
Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date:	March 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.71%
Avg Daily Range (30 D):	$0.72 | 2.85%
Avg Daily Range (90 D):	$0.88 | 3.01%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	1.28M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	168
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	685
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$5.27M
Avg Institutional Trade (90 D):	$3.82M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.55M
Avg Closing Trade (30 D):	$6.4M
Avg Closing Trade (90 D):	$5.03M
Avg Closing Volume:	137.76K

News

May 26, 2026 @ 5:00 PM Duchenne Muscular Dystrophy Clinical Trial Pipelin... Source: Delveinsight

May 10, 2026 @ 11:01 AM Capricor's Insider Just Sold Big — Her Opti... Source: Seena Hassouna

Dec 3, 2025 @ 7:21 PM Capricor Stock Soars, Shkreli Is Short: Here's Wha... Source: Erica Kollmann

Sep 25, 2025 @ 3:16 PM Why Capricor Therapeutics Stock Is Surging Today Source: Alex Perry

Sep 15, 2025 @ 7:58 PM Shareholders of Capricor Therapeutics, Inc. Should... Source: The Gross Law Firm

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.59	$-.54	$-.57
Diluted EPS	$-.59	$-.54	$-.57
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-33.94M	$-24.57M	$-25.91M
Operating Income / Loss	$-36.77M	$-26.28M	$-27.72M
Cost of Revenue
Net Cash Flow	$-182.43M	$-3.73M	$-5.55M
PE Ratio

Splits
Jun 05, 2019	1:10
Nov 21, 2013	1:50
Feb 09, 2007	1:10
Apr 05, 2005	1:20